Context Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

At the same time. The evidence so far has not been conclusive about whether convalesce convalescent plasma works, twhowhen to administer it and what dose to use. Kelly, what do we expect to hear . Reporter here it is a sunday evening on the eve of the president s own Political Convention and theres an announcement about a potential treatment option for doctors and their patients who have coronavirus. The timing is interesting. Is it being done safely . Those are some of the questions well put to the president. Our understanding is the president would announce this use of con velescent plasma. ...

CTIM-76Phase 1 clinical trial to focus on CLDN6-positive gynecologic and testicular cancers

Financing includes new and existing leading healthcare investors

Context Therapeutics Inc. (NASDAQ:CNTX – Get Free Report) saw a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 17,000 shares, an increase of 57.4% from the February 29th total of 10,800 shares. Approximately 0.1% of the company’s shares are short sold. Based on an […]

Context Therapeutics Inc. (NASDAQ:CNTX – Get Free Report) was the target of a significant increase in short interest in March. As of March 15th, there was short interest totalling 17,000 shares, an increase of 57.4% from the February 29th total of 10,800 shares. Currently, 0.1% of the company’s shares are short sold. Based on an […]